Elsa M. Laughlin

1.2k total citations
9 papers, 777 citations indexed

About

Elsa M. Laughlin is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Elsa M. Laughlin has authored 9 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Elsa M. Laughlin's work include Immune Cell Function and Interaction (4 papers), Diabetes and associated disorders (3 papers) and T-cell and B-cell Immunology (3 papers). Elsa M. Laughlin is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Diabetes and associated disorders (3 papers) and T-cell and B-cell Immunology (3 papers). Elsa M. Laughlin collaborates with scholars based in United States, Switzerland and India. Elsa M. Laughlin's co-authors include Steven G. Reed, Rhea N. Coler, Sylvie Bertholet, Susan L. Baldwin, Thomas S. Vedvick, Gerald T. Nepom, Ben Falk, Malcolm S. Duthie, Magdalini Moutaftsi and Hillarie Plessner Windish and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Diabetes.

In The Last Decade

Elsa M. Laughlin

9 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elsa M. Laughlin United States	9	374	275	232	187	150	9	777
Mimi Guebre‐Xabier United States	15	335 0.9×	279 1.0×	277 1.2×	150 0.8×	182 1.2×	24	858
Lasse Eggers Pedersen Denmark	11	504 1.3×	166 0.6×	134 0.6×	41 0.2×	491 3.3×	15	964
Efrosinia O. Krejany Australia	11	97 0.3×	58 0.2×	203 0.9×	231 1.2×	127 0.8×	19	607
E Filley United Kingdom	9	160 0.4×	223 0.8×	238 1.0×	33 0.2×	94 0.6×	11	493
Lyn M. O’Brien United Kingdom	16	317 0.8×	191 0.7×	362 1.6×	148 0.8×	165 1.1×	34	830
Thorsten Thye Germany	14	258 0.7×	361 1.3×	405 1.7×	50 0.3×	152 1.0×	33	733
Mischo Kursar Germany	18	1.0k 2.7×	315 1.1×	332 1.4×	47 0.3×	197 1.3×	21	1.3k
Daniela Fusco Germany	10	76 0.2×	278 1.0×	45 0.2×	41 0.2×	77 0.5×	25	471
Hiroyuki Saiga Japan	11	489 1.3×	495 1.8×	277 1.2×	113 0.6×	387 2.6×	19	1.2k
Asma Ahmed India	17	427 1.1×	264 1.0×	362 1.6×	43 0.2×	249 1.7×	51	898

Countries citing papers authored by Elsa M. Laughlin

Since Specialization

Citations

This map shows the geographic impact of Elsa M. Laughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa M. Laughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa M. Laughlin more than expected).

Fields of papers citing papers by Elsa M. Laughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsa M. Laughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa M. Laughlin. The network helps show where Elsa M. Laughlin may publish in the future.

Co-authorship network of co-authors of Elsa M. Laughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Elsa M. Laughlin. A scholar is included among the top collaborators of Elsa M. Laughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsa M. Laughlin. Elsa M. Laughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Coler, Rhea N., Sylvie Bertholet, Magdalini Moutaftsi, et al.. (2011). Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant. PLoS ONE. 6(1). e16333–e16333. 250 indexed citations

Chakravarty, Jaya, Sonali Trivedi, Anup Singh, et al.. (2011). A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis. Vaccine. 29(19). 3531–3537. 120 indexed citations

Bertholet, Sylvie, David Horné, Elsa M. Laughlin, et al.. (2011). Effect of Chemotherapy on Whole-Blood Cytokine Responses to Mycobacterium tuberculosis Antigens in a Small Cohort of Patients with Pulmonary Tuberculosis. Clinical and Vaccine Immunology. 18(8). 1378–1386. 15 indexed citations

Llanos‐Cuentas, Alejandro, María Cruz, Jill A. Ashman, et al.. (2010). A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis. Vaccine. 28(46). 7427–7435. 48 indexed citations

Laughlin, Elsa M., George W. Burke, Alberto Pugliese, Ben Falk, & Gerald T. Nepom. (2008). Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation. Clinical Immunology. 128(1). 23–30. 59 indexed citations

Bertholet, Sylvie, Gregory C. Ireton, Maria Kahn, et al.. (2008). Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis. The Journal of Immunology. 181(11). 7948–7957. 141 indexed citations

Laughlin, Elsa M., Joseph D. Miller, Eddie A. James, et al.. (2007). Antigen-Specific CD4⁺T Cells Recognize Epitopes of Protective Antigen following Vaccination with an Anthrax Vaccine. Infection and Immunity. 75(4). 1852–1860. 21 indexed citations

Mallone, Roberto, Sharon A. Kochik, Elsa M. Laughlin, et al.. (2004). Differential Recognition and Activation Thresholds in Human Autoreactive GAD-Specific T-Cells. Diabetes. 53(4). 971–977. 35 indexed citations

Reijonen, Helena, Roberto Mallone, Anne‐Kristin Heninger, et al.. (2004). GAD65-Specific CD4+ T-Cells with High Antigen Avidity Are Prevalent in Peripheral Blood of Patients With Type 1 Diabetes. Diabetes. 53(8). 1987–1994. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact